Thalassemia Market Research by Treatment Type, Type, Distribution Channel, and Region - Global Forecasts 2034-2034
Global Thalassemia Market Global Thalassemia Market Dublin, Jan. 31, 2025 (GLOBE NEWSWIRE) -- The "Thalassemia Market by ...
Novartis AG: Balancing Strong Performance with Future Challenges – Hold Rating Maintained
In a report released today, Eric Le Berrigaud from Stifel Nicolaus maintained a Hold rating on Novartis AG (NOVN – Research Report), with a ...
News Highlights: Top Company News of the Day - Friday at 5 AM ET
The pharma major beat analysts' expectations in the fourth quarter of 2024, despite looming competition for its top heart drug Entresto. The watchdog blocked access to DeepSeek after the companies ...
Novartis beats Q4 earnings consensus as drug sales surge
Novartis on Friday posted adjusted net income well above analyst estimates as sales of established heart failure drug ...
Novartis Expects Further Profit, Sales Growth Despite Competition Threat
The pharma major beat analysts’ expectations in the fourth quarter of 2024, despite looming competition for its top heart ...
Novartis Expects Further Profit, Sales Growth Despite Competition Threat — 2nd Update
Novartis said Friday that it expects core operating profit--one of its preferred metrics, which strips out exceptional items--for 2025 to grow in the high-single-digit to low-double-digit range and ...
Business Recorder59m
European shares at record peak as tech, healthcare lend support
European shares were at a record high on Friday, led by technology and healthcare stocks, even as caution prevailed ahead of ...